News
In terms of quality of life, someone 75 years old, retired with significant memory problems, can still have friends and, “a ...
As pharmaceutical companies struggle to develop Alzheimer’s treatments, scientists are searching for existing drugs that ...
Okanagan Clinical Trials is offering new opportunities for people to participate in important clinical research studies ...
18h
DPA International on MSNEMA recommends approval of additional Alzheimer's treatment
The European Medicines Agency (EMA) cleared the way for the use of another drug to treat Alzheimer's disease on Friday.
UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...
Dear Abby gives advice to a reader whose friend has been rude since being diagnosed with early Alzheimer’s disease.
A new study has explored a potential link between a particular sleep pattern and the risk of Alzheimer’s disease ...
Individuals treated for breast cancer often develop cognitive issues, but they may have a lower risk for developing Alzheimer ...
Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...
The combination of a recently approved blood test for detection of Alzheimer's disease combined with two medications that ...
The AFA opens a new Alzheimer’s support center in Amityville, offering programs, memory screenings and caregiver respite for ...
Without the receptor, ADGRG1, the microglia barely nibbled on the toxic protein. Using a mouse model of Alzheimer’s disease, the researchers observed how the loss of ADGRG1 led to the rapid buildup of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results